Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study

Abstract Background Ardisia gigantifolia Stapf. (AGS), a Chinese folk medicine widely grows in the south of China and several studies reported that AGS could inhibit the proliferation of breast cancer, liver cancer, and bladder cancer cell lines. However, little is known about its anti-colorectal ca...

Full description

Bibliographic Details
Main Authors: Weibo Dai, Jing Yang, Xin Liu, Quanxi Mei, Weijie Peng, Xianjing Hu
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-022-03822-8
_version_ 1828063911445790720
author Weibo Dai
Jing Yang
Xin Liu
Quanxi Mei
Weijie Peng
Xianjing Hu
author_facet Weibo Dai
Jing Yang
Xin Liu
Quanxi Mei
Weijie Peng
Xianjing Hu
author_sort Weibo Dai
collection DOAJ
description Abstract Background Ardisia gigantifolia Stapf. (AGS), a Chinese folk medicine widely grows in the south of China and several studies reported that AGS could inhibit the proliferation of breast cancer, liver cancer, and bladder cancer cell lines. However, little is known about its anti-colorectal cancer (CRC) efficiency. Methods In the present study, a combination of MTT assay, network pharmacological analysis, bioinformatics, molecular docking, and molecular dynamics simulation study was used to investigate the active ingredients, and targets of AGS against CRC, as well as the potential mechanism. Results MTT assay showed that three kinds of fractions from AGS, including the n-butanol extract (NBAGS), ethyl acetate fraction (EAAGS), and petroleum ether fraction (PEAGS) significantly inhibited the proliferation of CRC cells, with the IC50 values of 197.24, 264.85, 15.45 µg/mL on HCT116 cells, and 523.6, 323.59, 150.31 µg/mL on SW620 cells, respectively. Eleven active ingredients, including, 11-O-galloylbergenin, 11-O-protocatechuoylbergenin, 11-O-syringylbergenin, ardisiacrispin B, bergenin, epicatechin-3-gallate, gallic acid, quercetin, stigmasterol, stigmasterol-3-o-β-D-glucopyranoside were identified. A total of 173 targets related to the bioactive components and 21,572 targets related to CRC were picked out through database searching. Based on the crossover targets of AGS and CRC, a protein-protein interaction network was built up by the String database, from which it was concluded that the core targets would be SRC, MAPK1, ESR1, HSP90AA1, MAPK8. Besides, GO analysis showed that the numbers of biological process, cellular component, and molecular function of AGS against CRC were 1079, 44, and 132, respectively, and KEGG pathway enrichment indicated that 96 signaling pathways in all would probably be involved in AGS against CRC, among which MAPK signaling pathway, lipid, and atherosclerosis, proteoglycans in cancer, prostate cancer, adherens junction would probably be the major pathways. The docking study verified that AGS had multiple ingredients and multiple targets against CRC. Molecular dynamics (MD) simulation analysis showed that the binding would be stable via forming hydrogen bonds. Conclusion Our study showed that AGS had good anti-CRC potency with the characteristics of multi-ingredients, -targets, and -signaling pathways.
first_indexed 2024-04-10T22:50:32Z
format Article
id doaj.art-80848fface394b16945de74a0b892484
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-04-10T22:50:32Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-80848fface394b16945de74a0b8924842023-01-15T12:04:21ZengBMCBMC Complementary Medicine and Therapies2662-76712023-01-0123112310.1186/s12906-022-03822-8Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking studyWeibo Dai0Jing Yang1Xin Liu2Quanxi Mei3Weijie Peng4Xianjing Hu5Pharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese MedicinePharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese MedicinePharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese MedicineShenzhen Baoan Authentic TCM Therapy HospitalPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese MedicineGuangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical UniversityAbstract Background Ardisia gigantifolia Stapf. (AGS), a Chinese folk medicine widely grows in the south of China and several studies reported that AGS could inhibit the proliferation of breast cancer, liver cancer, and bladder cancer cell lines. However, little is known about its anti-colorectal cancer (CRC) efficiency. Methods In the present study, a combination of MTT assay, network pharmacological analysis, bioinformatics, molecular docking, and molecular dynamics simulation study was used to investigate the active ingredients, and targets of AGS against CRC, as well as the potential mechanism. Results MTT assay showed that three kinds of fractions from AGS, including the n-butanol extract (NBAGS), ethyl acetate fraction (EAAGS), and petroleum ether fraction (PEAGS) significantly inhibited the proliferation of CRC cells, with the IC50 values of 197.24, 264.85, 15.45 µg/mL on HCT116 cells, and 523.6, 323.59, 150.31 µg/mL on SW620 cells, respectively. Eleven active ingredients, including, 11-O-galloylbergenin, 11-O-protocatechuoylbergenin, 11-O-syringylbergenin, ardisiacrispin B, bergenin, epicatechin-3-gallate, gallic acid, quercetin, stigmasterol, stigmasterol-3-o-β-D-glucopyranoside were identified. A total of 173 targets related to the bioactive components and 21,572 targets related to CRC were picked out through database searching. Based on the crossover targets of AGS and CRC, a protein-protein interaction network was built up by the String database, from which it was concluded that the core targets would be SRC, MAPK1, ESR1, HSP90AA1, MAPK8. Besides, GO analysis showed that the numbers of biological process, cellular component, and molecular function of AGS against CRC were 1079, 44, and 132, respectively, and KEGG pathway enrichment indicated that 96 signaling pathways in all would probably be involved in AGS against CRC, among which MAPK signaling pathway, lipid, and atherosclerosis, proteoglycans in cancer, prostate cancer, adherens junction would probably be the major pathways. The docking study verified that AGS had multiple ingredients and multiple targets against CRC. Molecular dynamics (MD) simulation analysis showed that the binding would be stable via forming hydrogen bonds. Conclusion Our study showed that AGS had good anti-CRC potency with the characteristics of multi-ingredients, -targets, and -signaling pathways.https://doi.org/10.1186/s12906-022-03822-8Ardisia gigantifolia StapfChinese herbal medicineColorectal cancerNetwork pharmacologyMechanism predictionMolecular docking
spellingShingle Weibo Dai
Jing Yang
Xin Liu
Quanxi Mei
Weijie Peng
Xianjing Hu
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
BMC Complementary Medicine and Therapies
Ardisia gigantifolia Stapf
Chinese herbal medicine
Colorectal cancer
Network pharmacology
Mechanism prediction
Molecular docking
title Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
title_full Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
title_fullStr Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
title_full_unstemmed Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
title_short Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
title_sort anti colorectal cancer of ardisia gigantifolia stapf and targets prediction via network pharmacology and molecular docking study
topic Ardisia gigantifolia Stapf
Chinese herbal medicine
Colorectal cancer
Network pharmacology
Mechanism prediction
Molecular docking
url https://doi.org/10.1186/s12906-022-03822-8
work_keys_str_mv AT weibodai anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy
AT jingyang anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy
AT xinliu anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy
AT quanximei anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy
AT weijiepeng anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy
AT xianjinghu anticolorectalcancerofardisiagigantifoliastapfandtargetspredictionvianetworkpharmacologyandmoleculardockingstudy